// App-Quantinova.ai

: Six-Month Doxycycline Is Safe and Effective As Upfront Monotherapy for Stage-I Malt Lymphoma of the Ocular Adnexae: Primary Endpoint Results of the IELSG39 Trial

Researchers

Presenter

  • Andres J.M. Ferreri

Principal Investigators

  • Maria Giulia Cangi

  • Gilda Magliacane

  • Stefania Zanussi

  • Elena Flospergher

  • Fabrizio Marino

  • Lucia Bongiovanni

  • Marco Ladetto

  • Federica Cavallo

  • Franco Aversa

  • Antonella Anastasia

  • Donato Mannina

  • Anna Pascarella

  • Daniele Vallisa

  • Alessandro Pulsoni

  • Luisella Bonomini

  • Francesco Bertoni

  • Riccardo Dolcetti

  • Emanuele Zucca

  • Maurilio Ponzoni

Medical Centers

  • Pathology Unit, Ateneo Vita-Salute San Raffaele University, Milan, Italy

  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia

  • Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland

  • Pathology Unit, IRCCS San Raffaele Scientific Institute, Milano, ITA

  • International Extranodal Lymphoma Study Group, Institute of Oncology Research, Bellinzona, Switzerland

  • IRCCS San Raffaele Scientific Institute, Milano, Italy

  • Department of Hematology, ASST Spedali Civili, Brescia, Italy

  • Oncology-Hematology Department, Papardo Hospital, Messina, Italy

  • Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Turin, Italy

  • U.O. Ematologia, Ospedale dell'Angelo, Mestre-Venezia, Italy

  • Immunopathology and Cancer Biomarkers Unit, IRCCS National Cancer Institute, Aviano, Italy

  • Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland

  • Institute of Oncology Research (IOR), Bellinzona, Switzerland

  • Hematology Section, Department of Translational and Precision Medicine, Sapienza University of Rome, Italy, Rome, Italy

  • Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy

  • Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy

  • Emaologia e Centro Trapianti Midollo Osseo, Azienda Ospedaliero Universitaria di Parma, Parma, Italy

  • Dipartimento di oncologia ed ematologia, Guglielmo da Saliceto Hospital, Piacenza, Italy

  • Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU Città della Salute e della Scienza di Torino, Turin, Italy

  • Università della Svizzera Italiana - Faculty of Biomedical Sciences, Bellinzona, Switzerland

Locations

  • Italy

  • Australia

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Central Nervous System (CNS)

  • Autoimmune (AI)

Disease

  • Lupus

  • Myasthenia gravis

  • Mucosa-associated lymphoid tissue lymphoma

  • Lymphomas

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Doxycycline

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved